Evidence map›Paper›PMID 29644616›Full record

ArticleEnvironmental science and pollution research international2018

Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.

Diaa A Hameed, Heba A Yassa, Michael N Agban, Randa T Hanna, Ahmed M Elderwy, Mohamed A Zwaita

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Diaa A HameedUrology Department, Assiut University, Assiut, Egypt.
Heba A YassaForensic Medicine and Clinical Toxicology Department, Assiut University, Assiut, Egypt. hebayassa@aun.edu.ORCID http://orcid.org/0000-0001-9239-7049
Michael N AgbanMicrobiology Department, Assiut University, Assiut, Egypt.
Randa T HannaBiochemistry Department, Assiut University, Assiut, Egypt.
Ahmed M ElderwyUrology Department, Assiut University, Assiut, Egypt.
Mohamed A ZwaitaUrology Department, Assiut University, Assiut, Egypt.
Assiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Egypt, bladder cancer is one of the most popular cancers, accounting for 31% of all cancer cases. It ranks first in males about 16.2% of male cancer. The incidence in rural areas among males is near 32 per 100,000. The exact etiology of bladder cancer is still unknown; K-ras gene is known as a critical DNA target for chemical carcinogens such as pesticide. Some occupational hazard exposure is thought to be directly genotoxic, while others might enhance the mutagenicity and carcinogenicity of directly acting genotoxic agents. Analysis of the relationship between pesticide exposure and mutation in the K-ras gene in human bladder cancer. One hundred patients were diagnosed with bladder cancer and two hundred controls attended the outpatient clinic; after taking consent and filling a questionnaire for age, sex, occupation and pesticide exposure, surgically resected specimens were collected and the samples were used to determine the k-ras mutation. Blood samples were taken to analyze the level of acetylcholinesterase enzyme and level of P

Indexed as

Genes, rasAgedCarcinogensCarcinomaCase-Control StudiesEgyptFemaleHumansMaleMiddle AgedMutationOccupational ExposurePesticidesProto-Oncogene MasUrinary Bladder NeoplasmsCarcinogensMAS1 protein, humanPesticidesProto-Oncogene MasAcetylcholinesteraseBladder cancerK-rasMutation

Identifiers

PMID29644616
OpenAlexW2797303473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.